Efficacy of pharmacotherapy for weight loss in adults with type 2 diabetes mellitus: a meta-analysis.

@article{Norris2004EfficacyOP,
  title={Efficacy of pharmacotherapy for weight loss in adults with type 2 diabetes mellitus: a meta-analysis.},
  author={Susan L Norris and X Zhang and A Avenell and Edward Gregg and Christopher H. Schmid and Curi Kim and Joseph Lau},
  journal={Archives of internal medicine},
  year={2004},
  volume={164 13},
  pages={1395-404}
}
BACKGROUND Obesity is closely related to type 2 diabetes mellitus, and weight reduction is an important part of the care delivered to obese persons with diabetes. The objective of this review was to assess the efficacy of pharmacotherapy for weight loss in adults with type 2 diabetes. METHODS A systematic review of the literature was performed, and studies were included if pharmacotherapy was used as the primary strategy for weight loss among adults with type 2 diabetes. Published and… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 53 extracted citations

Umfassende Betreuung von adipösen Patienten

Der Diabetologe • 2006
View 4 Excerpts
Highly Influenced

Pharmacological treatment of the overweight patient.

Pharmacological reviews • 2007
View 2 Excerpts
Highly Influenced

References

Publications referenced by this paper.
Showing 1-10 of 74 references

Latin-American multicentric study with orlistat in overweight or obese patients with type 2 diabetes [abstract]. Diabetes. 2001;50(suppl 2):A437

A. Halpern
(REPRINTED) ARCH INTERN MED/ • 2004

Role of sibutramine in the (REPRINTED) ARCH INTERN MED

M Serrano-Rios, N Meichionda, E. Moreno-Carretero
VOL 164, JULY 12, • 2004

Petition to FDA to ban the diet drug sibutramine (MERIDIA) (HRG Publication #1613) [Public Citizen Web site

S Wolfe, LD Sasich, E. Barbehenn
March 19, • 2002

Similar Papers

Loading similar papers…